Nektar Presents New Responder Data for Rezpegaldesleukin, a

Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress

Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Alabama , United States , San Francisco , California , Jonathan Silverberg , Vivian Wu , Jonathan Zalevsky , David Rosen , Nektar Therapeutics , George Washington University School Of Medicine , Exchange Commission , Research Development , Clinical Research , European Academy Of Dermatology , Health Sciences , Rapid Onset , Continuing Benefit , Week Treatment Period , New Data Presented Show Encouraging Proportion , Patient Reported Responder Outcomes , George Washington University School , Contact Dermatitis , Eczema Area , Severity Index , Validated Investigator Global Assessment , Body Surface Area , Itch Numeric Rating Scale , Daily Life Quality Index , Patient Oriented Eczema Measure , Senior Vice President , Chief Research , Development Officer , Who Achieved , Patients Who Achieved , Single Agent Rezpegaldesleukin , Selective Regulatoryt Cell Inducing , Atopic Dermatitis , Final Results , Randomized Phase , Late Breaking , Placebo Controlled Study , Moderate To Severe Atopic Dermatitis , Annual Report ,